BSE filing, NSE: MAYURUNIQ. Summary written from the filing by ALFA Finder's alert engine.
Mayur Uniquoters Ltd: key numbers
- Share price
- ₹715.45
- Market cap
- ₹3,109 Cr
- Revenue (annual)
- ₹967.0 Cr
- Net profit (annual)
- ₹191.7 Cr
- P/E (TTM)
- 15.0×Sector 50.0×
- Promoter holding
- 58.80%+0.03% QoQ
- FII holding
- 5.28%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Mayur Uniquoters Ltd
All →Mayur Uniquoters Board Meeting Date
Mayur Uniquoters will hold a board meeting on November 4, 2026 to approve unaudited Q2 and half-year results. The meeting will also consider the limited review report.
Mayur Uniquoters Management Change
Mayur Uniquoters Limited announced the resignation of Mr. Ashutosh Pandey, General Manager – Marketing, effective October 09, 2026, as he pursues other career opportunities.
Mayur Uniquoters Other Announcement
Mayur Uniquoters Ltd has filed its quarterly certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.
Mayur Uniquoters Promoter Buying: ₹0.07 Cr
Promoter Kiran Poddar bought 1,000 equity shares worth ₹0.07 Crore via open market. This transaction increases their stake in the company by 0.01%.
- Value
- ₹0.07 Cr
- Promoter stake change
- +0.01%
Mayur Uniquoters Promoter Buying
Kiran Poddar, a promoter group member of Mayur Uniquoters Limited, acquired 1,000 equity shares via the open market. This transaction increased the total promoter group stake to 58.80%.
- Promoter stake change
- +0.01%
Mayur Uniquoters Promoter Buying: ₹0.14 Cr
Promoter Kiran Poddar acquired 2,000 shares of Mayur Uniquoters Ltd from the open market for ₹0.14 Crore. The transaction increases the promoter's stake.
- Value
- ₹0.14 Cr
Other adverse business impact announcements
All →Medplus Health Services Adverse Business Impact
MedPlus Health Services' subsidiary Optival Health Solutions had its drug licence suspended for five days for a Suryapet store. Expected financial impact is about Rs 1.32 lakh.
- Value
- ₹0.01 Cr
- Execution
- 05 days
Oriental Rail Infrastructure Adverse Business Impact
Oriental Rail's subsidiary Oriental Foundry had a fire at its Kutch plant on 28 October 2026. Damage is minimal, operations are unaffected and the loss is insured.
Capillary Technologies India Adverse Business Impact
Capillary Technologies received KPMG's final forensic report on a cyber-enabled payment fraud at a step-down subsidiary. Four disputed payments totalled EUR 3.04 million, about Rs.32.24 Crore.
- Value
- ₹32.24 Cr
Windlas Biotech Adverse Business Impact
Windlas Biotech disclosed a cyber security incident on 30 October 2026. It states no material impact on core operations, finances or business continuity.
Neogen Chemicals Adverse Business Impact
Neogen Chemicals reports continued fire disruption at MPP3; replacement plant partly built with trial runs underway. Recognized damage totals ₹348.16 crore; production shifted to other sites.
- Value
- ₹348.2 Cr
Hindustan Organic Chemicals Adverse Business Impact
Hindustan Organic Chemicals temporarily shuts down its Kochi Hydrogen plant from 29 October 2026 for pipeline repair and urgent maintenance. Reopening date to be communicated separately.